Cargando…
Engineering of Bispecific Affinity Proteins with High Affinity for ERBB2 and Adaptable Binding to Albumin
The epidermal growth factor receptor 2, ERBB2, is a well-validated target for cancer diagnostics and therapy. Recent studies suggest that the over-expression of this receptor in various cancers might also be exploited for antibody-based payload delivery, e.g. antibody drug conjugates. In such strate...
Autores principales: | Nilvebrant, Johan, Åstrand, Mikael, Georgieva-Kotseva, Maria, Björnmalm, Mattias, Löfblom, John, Hober, Sophia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4121139/ https://www.ncbi.nlm.nih.gov/pubmed/25089830 http://dx.doi.org/10.1371/journal.pone.0103094 |
Ejemplares similares
-
Engineering Bispecificity into a Single Albumin-Binding Domain
por: Nilvebrant, Johan, et al.
Publicado: (2011) -
Orthogonal Protein Purification Facilitated by a Small Bispecific Affinity Tag
por: Nilvebrant, Johan, et al.
Publicado: (2012) -
Small Bispecific Affinity Proteins for Simultaneous
Target Binding and Albumin-Associated Half-Life Extension
por: von Witting, Emma, et al.
Publicado: (2020) -
Correction
to “Small Bispecific Affinity Proteins
for Simultaneous Target Binding and Albumin-Associated Half-Life Extension”
por: von Witting, Emma, et al.
Publicado: (2022) -
The albumin-binding domain as a scaffold for protein engineering
por: Nilvebrant, Johan, et al.
Publicado: (2013)